About Knome
Knome is a company based in Cambridge (United States) founded in 2007 was acquired by Tute Genomics in November 2015. It operates as a SaaS (Software-as-a-Service) and Professional Services. Knome has raised $25 million across 5 funding rounds from investors including Tute Genomics. The company has 18 employees as of December 31, 2014. Knome offers products and services including knoSYS and knomeDISCOVERY. Knome operates in a competitive market with competitors including DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
- Headquarter Cambridge, United States
- Employees 18 as on 31 Dec, 2014
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Knome Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25 M (USD)
in 5 rounds
-
Latest Funding Round
$13 M (USD), Series B
Jan 10, 2014
- Investors
-
Employee Count
18
as on Dec 31, 2014
-
Acquired by
Tute Genomics
(Nov 02, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Knome
Knome offers a comprehensive portfolio of products and services, including knoSYS and knomeDISCOVERY.
A system for analyzing and interpreting genomic data.
End-to-end solution for studying human genomic data.
Funding Insights of Knome
Knome has successfully raised a total of $25M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $13 million completed in January 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Knome
Knome has secured backing from 1 investor. Prominent investors backing the company include Tute Genomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cloud-based genome analysis for precision medicine is provided.
|
Locked | Locked | Locked |
Investor details for Knome
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Knome
Investment portfolio details for Knome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Knome
Detailed financials for Knome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Knome Comparisons
Peer comparison for Knome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Knome
Knome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
Platforms for genomic data analysis and management are provided.
|
Detailed competitors of Knome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Knome
Complete news archive for Knome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Knome
Knome was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Knome is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Knome is a funded company, having raised a total of $25M across 5 funding rounds to date.
As of Dec 31, 2014, the latest employee count at Knome is 18.
Knome is involved in delivering bioinformatics infrastructure and insights for translational genomics initiatives. The company supports clinical NGS testing programs through scalable informatics systems like knoSYS for genome and exome data analysis. Additionally, research services such as knomeDISCOVERY are offered to pharmaceutical and academic researchers for studying large-scale human genomic data. Solutions are tailored to empower partners in advancing pharmaceutical success across healthcare and biotechnology sectors.
Knome's top competitors include DNAnexus, Depixus and Ingenuity Systems.
Knome offers knoSYS and knomeDISCOVERY.
Knome has 1 investor. Key investors include Tute Genomics.